Cargando…

Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column

We report the first rapid ultra-high performance liquid chromatographic (UHPLC) enantiomeric reversed-phase separation of rasagiline mesylate and its tartrate salts using a Chiralpak(®) AGP column (50 mm × 2.1 mm, 5 μm) as a stationary phase. This method was developed as an alternative to the usage...

Descripción completa

Detalles Bibliográficos
Autores principales: Balaji, Nagarajan, Sultana, Sayeeda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620514/
https://www.ncbi.nlm.nih.gov/pubmed/28753970
http://dx.doi.org/10.3390/scipharm85030026
_version_ 1783267600582574080
author Balaji, Nagarajan
Sultana, Sayeeda
author_facet Balaji, Nagarajan
Sultana, Sayeeda
author_sort Balaji, Nagarajan
collection PubMed
description We report the first rapid ultra-high performance liquid chromatographic (UHPLC) enantiomeric reversed-phase separation of rasagiline mesylate and its tartrate salts using a Chiralpak(®) AGP column (50 mm × 2.1 mm, 5 μm) as a stationary phase. This method was developed as an alternative to the usage of previously reported normal-phase chiral LC columns for isomer separation. Our method is based on an isocratic approach using a mixture of ammonium acetate and isopropyl alcohol (90:10, v/v) as the mobile phase (0.6 mL/min flow rate). The detection limit (at a detection wavelength of 210 nm) and quantification limit for the rasagiline enantiomers were 0.06 and 0.2 μg/mL, respectively. This method is compatible with the UHPLC-MS technique. The successful separation of rasagiline and its enantiomer was confirmed by determining the corresponding specific optical rotation values. Our method will be applicable for detecting rasagiline enantiomers during the control of manufacturing processes, and for use in rapid analysis for quality control in pharmaceutical industry to obtain optically pure pharmaceutical substances. This method was validated in terms of its precision, limit of detection, limit of quantification, linearity, accuracy, robustness, ruggedness, specificity, forced degradation, and solution stability, according to International Council on Harmonization Validation Guidelines Q2 (R1).
format Online
Article
Text
id pubmed-5620514
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-56205142017-10-06 Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column Balaji, Nagarajan Sultana, Sayeeda Sci Pharm Article We report the first rapid ultra-high performance liquid chromatographic (UHPLC) enantiomeric reversed-phase separation of rasagiline mesylate and its tartrate salts using a Chiralpak(®) AGP column (50 mm × 2.1 mm, 5 μm) as a stationary phase. This method was developed as an alternative to the usage of previously reported normal-phase chiral LC columns for isomer separation. Our method is based on an isocratic approach using a mixture of ammonium acetate and isopropyl alcohol (90:10, v/v) as the mobile phase (0.6 mL/min flow rate). The detection limit (at a detection wavelength of 210 nm) and quantification limit for the rasagiline enantiomers were 0.06 and 0.2 μg/mL, respectively. This method is compatible with the UHPLC-MS technique. The successful separation of rasagiline and its enantiomer was confirmed by determining the corresponding specific optical rotation values. Our method will be applicable for detecting rasagiline enantiomers during the control of manufacturing processes, and for use in rapid analysis for quality control in pharmaceutical industry to obtain optically pure pharmaceutical substances. This method was validated in terms of its precision, limit of detection, limit of quantification, linearity, accuracy, robustness, ruggedness, specificity, forced degradation, and solution stability, according to International Council on Harmonization Validation Guidelines Q2 (R1). MDPI 2017-07-19 2017 /pmc/articles/PMC5620514/ /pubmed/28753970 http://dx.doi.org/10.3390/scipharm85030026 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Balaji, Nagarajan
Sultana, Sayeeda
Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column
title Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column
title_full Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column
title_fullStr Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column
title_full_unstemmed Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column
title_short Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column
title_sort reversed-phase uhplc enantiomeric separation of rasagiline salts using a chiralpak(®) agp column
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620514/
https://www.ncbi.nlm.nih.gov/pubmed/28753970
http://dx.doi.org/10.3390/scipharm85030026
work_keys_str_mv AT balajinagarajan reversedphaseuhplcenantiomericseparationofrasagilinesaltsusingachiralpakagpcolumn
AT sultanasayeeda reversedphaseuhplcenantiomericseparationofrasagilinesaltsusingachiralpakagpcolumn